Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies
21 nov. 2024 09h24 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company that licenses innovations from Purdue Research Foundation, has developed a patent-pending antiviral...
Purdue innovations detect lead exposure faster, easier and with greater precision at the point of care
31 oct. 2024 09h57 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Exposure to lead can adversely impact people’s health in several ways. A Purdue University researcher in the College of Health and Human...
Biotech company Eradivir closes $10.25M Series A funding round to complete Phase 2a study of influenza therapeutic
25 sept. 2024 10h00 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round. The...
Biotech company Eradivir is developing lead drug EV25 to treat influenza
09 juil. 2024 14h24 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., July 09, 2024 (GLOBE NEWSWIRE) -- Eradivir, a preclinical biotech company, leverages small molecule targeting technology developed in Philip Low’s lab at Purdue University to...
From eureka moments to industry impact: Tillmann Kubis’ quantum code library
08 juil. 2024 10h59 HE
|
Purdue Research Foundation
WEST LAFAYETTE, IND., July 08, 2024 (GLOBE NEWSWIRE) -- You could talk to Tillmann Kubis for hours. His laid-back demeanor and desire for everyone to understand what he’s working on is so...
‘Like a hand fitting into a glove’: Purdue-engineered compound designed to treat drug-resistant acute myeloid leukemia
20 juin 2024 10h55 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., June 20, 2024 (GLOBE NEWSWIRE) -- Researchers at Purdue University’s College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute...
34 Lives has saved 10 lives with “unusable” kidneys — and they’re just getting started
19 juin 2024 15h07 HE
|
Purdue Research Foundation
WEST LAFAYETTE, IN, June 19, 2024 (GLOBE NEWSWIRE) -- New technologies are often referred to as life-changing, but that phrase quite literally describes the work that 34 Lives is doing for those...
Global Impact: Purdue University Airport a gateway to aviation innovation
14 mai 2024 14h06 HE
|
Purdue Research Foundation
WEST LAFAYETTE, IN, May 14, 2024 (GLOBE NEWSWIRE) -- Purdue University Airport (LAF) enters a new era on May 15th as it launches the first commercial air service since 2004, offering 4 weekly...
SK hynix announces semiconductor advanced packaging investment in Purdue Research Park
03 avr. 2024 16h25 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., April 03, 2024 (GLOBE NEWSWIRE) -- SK hynix Inc. announced Wednesday (April 3) that it plans to invest close to $4 billion to build an advanced packaging fabrication and...
Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa
15 sept. 2023 12h48 HE
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Sept. 15, 2023 (GLOBE NEWSWIRE) -- A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries. Open...